p Value | OR | 95% CI | |
---|---|---|---|
Age (years) | 0.988 | 0.998 | 0.741 to 1.344 |
Women (%) | 0.819 | 0.998 | 0.981 to 1.015 |
Body mass index (kg/m2) | 0.080 | 0.955 | 0.938 to 1.004 |
Persistent/permanent AF (%) | 0.573 | 0.919 | 0.687 to 1.231 |
Ankle-Brachial Index ≤0.90 (%) | 0.018 | 1.516 | 1.075 to 2.139 |
Arterial hypertension (%) | 0.017 | 1.830 | 1.113 to 3.009 |
Diabetes (%) | 0.485 | 0.883 | 0.622 to 1.253 |
Heart failure (%) | 0.969 | 0.993 | 0.683 to 1.443 |
History of stroke/TIA (%) | 0.176 | 0.723 | 0.452 to 1.156 |
History of MI/CHD (%) | 0.800 | 1.052 | 0.708 to 1.564 |
ACE inhibitors/ARBs (%) | 0.023 | 0.662 | 0.464 to 0.944 |
β blockers (%) | 0.215 | 1.206 | 0.897 to 1.621 |
Calcium channel antagonists (%) | 0.673 | 1.074 | 0.771 to 1.497 |
Statins (%) | 0.848 | 0.971 | 0.720 to 1.311 |
Antiplatelet (%) | 0.464 | 0.870 | 0.600 to 1.262 |
ACE, angiotensin converting enzyme; AF, atrial fibrillation; ARBs, angiotensin receptor blockers; CHD, coronary heart disease; eGFR, estimated glomerular filtration rate; MI, myocardial infarction; TIA, transient ischaemic attack.